Substance use disorders: sex differences and psychiatric comorbidities.
about
Age of onset and temporal sequencing of lifetime DSM-IV alcohol use disorders relative to comorbid mood and anxiety disordersEmergence of sex differences in the development of substance use and abuse during adolescenceTransforming growth factor beta receptor 1 is increased following abstinence from cocaine self-administration, but not cocaine sensitizationMad men, women and steroid cocktails: a review of the impact of sex and other factors on anabolic androgenic steroids effects on affective behaviorsDepressive symptoms moderate treatment response to brief intervention for prevention of alcohol exposed pregnancy.A network approach to modeling comorbid internalizing and alcohol use disorders.Women and Substance Abuse Problems.The role of oestradiol in sexually dimorphic hypothalamic-pituitary-adrena axis responses to intracerebroventricular ethanol administration in the ratBinge-pattern alcohol exposure during puberty induces sexually dimorphic changes in genes regulating the HPA axis.Thirty-day prevalence of DSM-IV mental disorders among nondeployed soldiers in the US Army: results from the Army Study to Assess Risk and Resilience in Servicemembers (Army STARRS).Binge-pattern alcohol exposure during puberty induces long-term changes in HPA axis reactivity.Prenatal alcohol exposure: fetal programming and later life vulnerability to stress, depression and anxiety disordersFurther characterization of quinpirole-elicited yawning as a model of dopamine D3 receptor activation in male and female monkeys.High psychiatric symptom severity is a moderator of substance abuse treatment outcomes among women in single vs. mixed gender group treatment.17β-Estradiol is required for the sexually dimorphic effects of repeated binge-pattern alcohol exposure on the HPA axis during adolescence.Marijuana craving during a public speaking challenge: Understanding marijuana use vulnerability among women and those with social anxiety disorderThe use of virtual reality in craving assessment and cue-exposure therapy in substance use disorders.Level and change in alcohol consumption, depression and dysfunctional attitudes among females treated for alcohol addiction.Sampling in Developmental Science: Situations, Shortcomings, Solutions, and Standards.Treatment outcomes for substance use disorder among women of reproductive age in Massachusetts: a population-based approachAn acute psychosocial stressor increases drinking in non-treatment-seeking alcoholics.The association of injury with substance use disorder among women of reproductive age: an opportunity to address a major contributor to recurrent preventable emergency department visits?The interacting effect of depressive symptoms, gender, and distress tolerance on substance use problems among residential treatment-seeking substance users.Craving in response to stress induction in a human laboratory paradigm predicts treatment outcome in alcohol-dependent individuals.Implementation and evaluation of a harm-reduction model for clinical care of substance using pregnant womenPathways to Vulnerability for Alcohol Problem Severity in a Treatment-Seeking Sample.Measurement of gender-sensitive treatment for women in mixed-gender substance abuse treatment programsSuicide risk among male substance users in residential treatment: Evaluation of the depression-distress amplification model.An exploratory investigation of marital functioning and order of spousal onset in couples concordant for psychopathology.Personality traits and psychiatric comorbidities in alcohol dependence.HIV Testing, Care, and Treatment Among Women Who Use Drugs From a Global Perspective: Progress and Challengesβ-endorphin modulates the effect of stress on novelty-suppressed feedingSex differences in the neural mechanisms mediating addiction: a new synthesis and hypothesisGender differences in substance use, consequences, motivation to change, and treatment seeking in people with serious mental illness.Gender differences in substance abuse treatment and barriers to care among persons with substance use disorders with and without comorbid major depression.Mental disorders as risk factors for later substance dependence: estimates of optimal prevention and treatment benefits.Sex differences in drug addiction: a review of animal and human studies.A measurement model of women's behavioral risk takingInsights in Public Health: Substance Use in Pregnant Women in Hawai'i: Extending Our Capacity and Compassion.The Psychiatric Morbidity of Women Who Give Birth to Children with Fetal Alcohol Spectrum Disorder (FASD): Results of the Manitoba Mothers and FASD Study.
P2860
Q24653863-BA4A6260-E5D9-49D9-ADC1-293FD3704293Q27022504-125BA02C-4118-41BF-B6F5-DF543CE5C040Q28538088-87DBC3FB-8C7B-4426-9CAB-9EE9A2DE8E3BQ30364736-E0356D88-A630-46FF-9B87-88A3C2BB11C4Q30410478-26579544-A318-4F54-A340-442BB0FDF851Q30844980-B26D2B43-939A-4BF4-A04C-4D5087CB86FFQ33206384-D59FF4A1-FA5D-469D-BEFF-611EB864ED14Q33638711-8F4C65B9-6E21-4C97-8F1C-FCE460392E17Q33655461-ACADF1A4-A1A0-4C13-8832-DFD30919D1A1Q33756883-D3A8416F-0407-4DB4-B680-68DD7353B2FEQ33886772-A96FD3E5-C8A6-4135-8852-3075896D5DFEQ33919857-DADBE34D-34F2-4611-B7AF-141E2A72CA00Q33944031-F0A9F41C-1FCA-495C-AE8E-EFB0ADAE42A3Q34051472-5867EF9E-FC11-4A1C-BACE-2FE0EC9C1BDAQ34182440-625C864E-45AD-431A-B4E4-006F2F57F124Q34311543-EF5A036B-0904-49CA-9848-B65E051B6C1CQ34359794-F01BE4DD-AD34-4235-A581-8548C9F84AAEQ34824905-22AA5D3B-2817-43F7-83C4-1B7094CDE124Q34858727-5DBED1C2-88BB-43EF-9EC8-2B09CF1ED9D9Q34980323-AF350226-0DD4-418D-92D5-3A7198F3CA31Q35046485-551213ED-62BF-4BE4-831B-6A7C9D54A807Q35088300-8C8B0B0A-BA64-4F3A-AB18-4C16A118F2F3Q35133392-5F2D5F1D-4B3E-4378-A907-751FB39ACF57Q35317385-4253E272-896F-4851-A886-A70CBEEF85E8Q35799895-F6208BEB-5553-4E37-BDDD-AAB91A56E4AAQ35838634-B278D644-80DD-498E-BB5F-E3AB48B4EA1BQ35871731-CAC01938-640F-4AE7-9AFF-D2157293827CQ35938010-1ADBB888-CD4E-4A52-BE9B-616CCCB874D0Q36357557-CA7735A5-FE88-402F-94A2-B43F0D640DDEQ36377521-8714DB08-E3FF-43EF-A664-65567297E54CQ36455197-3D11CC78-E825-4526-A388-CCBD3C96042BQ36682202-F26088E9-DD3D-4757-B8C1-7BD746603999Q37047922-CAB8480E-0405-4B83-AA88-C1CEA58DEA17Q37212858-49F1EAF0-1510-479D-87FF-70C56E860A1BQ37217206-590A36D2-2DBC-4624-A334-6913D22CAEC7Q37249662-35B5D253-CA1A-4806-8A68-0C88C4A38CA9Q37346080-B2251809-7CA4-4AB4-AF4E-60FB80763972Q37386796-D18D88FC-5631-429B-BA38-1F7412F3C23BQ37445455-EAAD775B-C04D-4886-A85F-BE3B48D03B79Q38761849-58E0306D-D9C5-482E-AB6B-3E097AA49748
P2860
Substance use disorders: sex differences and psychiatric comorbidities.
description
2003 nî lūn-bûn
@nan
2003 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Substance use disorders: sex differences and psychiatric comorbidities.
@ast
Substance use disorders: sex differences and psychiatric comorbidities.
@en
type
label
Substance use disorders: sex differences and psychiatric comorbidities.
@ast
Substance use disorders: sex differences and psychiatric comorbidities.
@en
prefLabel
Substance use disorders: sex differences and psychiatric comorbidities.
@ast
Substance use disorders: sex differences and psychiatric comorbidities.
@en
P2093
P2860
P1476
Substance use disorders: sex differences and psychiatric comorbidities.
@en
P2093
Hermano Tavares
Monica L Zilberman
Nady el-Guebaly
Sheila B Blume
P2860
P356
10.1177/070674370304800103
P407
P577
2003-02-01T00:00:00Z